A new European consensus statement offers expert guidance on which biomarkers to use for patients presenting with cognitive complaints. Led by Giovanni B. Frisoni, MD, Laboratory of Neuroimaging of ...

Neurocognitive disorders, mild and major, include a group of conditions which were once all grouped under the umbrella term “dementia.” The conditions involve similar cognitive impairments and decline ...

Neuropsychological assessment, or cognitive testing, is the gold standard tool for measuring cognitive functions (or the “software” of the brain) such as memory, language, attention, visuospatial ...

Brain age reveals measurable psychiatric differences, offering clinicians a promising biomarker to improve personalised ...

PND is a common and serious neurological complication in elderly patients during the perioperative period, significantly affecting postoperative cognitive function. Currently, the diagnosis of PND ...

As dementia cases continue to rise in the United States, new research from the University of Michigan School of Public Health reveals that older Americans with cumulative lead exposure face a ...

Investigators evaluated the long-term neurological, neurocognitive, social, and quality of life outcomes associated with posterior fossa syndrome among survivors of medulloblastoma.

Funding: This work was supported by the National Institute on Aging (R01 AG051125 (JL), R01 AG030153 (JL), U01 AG064948 (JL), R01 AG070953 (ALG)). The funders had no role in study design, data ...